» Articles » PMID: 19332249

Management of Advanced-stage and Recurrent Endometrial Cancer

Overview
Journal Semin Oncol
Specialty Oncology
Date 2009 Apr 1
PMID 19332249
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial carcinoma is frequently diagnosed at an early stage, at which point it is usually surgically curable. Some less common subtypes of endometrial carcinoma, such as serous and clear cell carcinomas, have a worse prognosis than most endometrioid carcinomas. Patients with advanced or recurrent disease, regardless of histologic subtype, have a poor prognosis. Both single-agent and combination chemotherapy regimens (such as doxorubicin, cisplatin, and paclitaxel) have antitumor activity but are not curative. Recently, adjuvant chemotherapy has been shown to improve outcomes in high-risk nonmetastatic (stage III) disease. Newer agents such as mammalian target of rapamycin (mTOR) inhibitors show promise, and are currently being tested in a clinical trials.

Citing Articles

Clinical significance of TROAP in endometrial cancer and the antiproliferative and proapoptotic effects of TROAP knockdown in endometrial cancer cells: integrated utilization of bioinformatic analysis and in vitro test verification.

Qiao Y, Chen Z, Li W, Li H, Zhou L Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):10049-10059.

PMID: 38967825 DOI: 10.1007/s00210-024-03260-y.


LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis.

Liu Y, Yuan S, Liu X, Huang Y, Qiu P, Gao J J Mol Med (Berl). 2022; 100(9):1271-1286.

PMID: 35788718 DOI: 10.1007/s00109-022-02222-2.


LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR-665/HOXB5 and MiR-873-5p/CADM1 Pathways.

Wang J, Lei C, Shi P, Teng H, Lu L, Guo H Front Oncol. 2021; 11:714652.

PMID: 34497766 PMC: 8420713. DOI: 10.3389/fonc.2021.714652.


Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line.

Aydemir I, Turkoz Uluer E, Korkmaz O, Tuglu M, Inan S Rom J Morphol Embryol. 2021; 61(3):707-714.

PMID: 33817712 PMC: 8112780. DOI: 10.47162/RJME.61.3.09.


MicroRNA-15a-5p inhibits endometrial carcinoma proliferation, invasion and migration via downregulation of VEGFA and inhibition of the Wnt/β-catenin signaling pathway.

Wang H, Yang Q, Li J, Chen W, Jin X, Wang Y Oncol Lett. 2021; 21(4):310.

PMID: 33732386 PMC: 7905532. DOI: 10.3892/ol.2021.12570.